The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

Clinical trial NCT05012943 · COMPLETED

Trial details

NCT number: NCT05012943
Sponsor: Vinbiocare Biotechnology Joint Stock Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Vaccines

Start date: 2021-08-15
Primary completion: 2023-01-18
Enrollment: 19474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.